EX-99.2 3 dex992.htm CRANE CO. QUARTERLY FINANCIAL DATA SUPPLEMENT Crane Co. Quarterly Financial Data Supplement

 

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2010     2009     2010     2009  

Net Sales:

        

Aerospace & Electronics

   $ 143,161      $ 136,896      $ 416,105      $ 435,838   

Engineered Materials

     54,904        48,065        167,305        127,990   

Merchandising Systems

     77,199        75,879        221,897        220,905   

Fluid Handling

     255,842        266,810        758,218        796,383   

Controls

     29,608        23,060        80,294        70,223   
                                

Total Net Sales

   $ 560,714      $ 550,710      $ 1,643,819      $ 1,651,339   
                                

Operating Profit:

        

Aerospace & Electronics

   $ 25,368      $ 19,928      $ 76,072      $ 56,259   

Engineered Materials

     7,965        7,530        26,677        13,597   

Merchandising Systems

     6,261        6,914        19,340        16,569   

Fluid Handling

     33,197        34,882        93,338        98,708   

Controls

     1,949        (1,667     2,900        (2,984

Corporate

     (11,861     (12,134     (36,864     (43,320 ) * 
                                

Total Operating Profit

     62,879        55,453        181,463        138,829   

Interest Income

     299        270        760        1,578   

Interest Expense

     (6,738     (6,821     (20,121     (20,370

Miscellaneous-Net

     1,522        83        897        2,323   
                                

Income Before Income Taxes

     57,962        48,985        162,999        122,360   

Provision for Income Taxes

     16,359        13,832        48,049        35,973   
                                

Net income before allocations to noncontrolling interests

     41,603        35,153        114,950        86,387   

Less: Noncontrolling interest in subsidiaries’ earnings

     96        45        168        202   
                                

Net income attributable to common shareholders

     41,507        35,108        114,782        86,185   
                                

Share Data:

        

Earnings per Diluted Share

   $ 0.70      $ 0.60      $ 1.92      $ 1.47   
                                

Average Diluted Shares Outstanding

     59,525        58,842        59,645        58,703   

Average Basic Shares Outstanding

     58,608        58,472        58,710        58,462   

Supplemental Data:

        

Cost of Sales

   $ 373,171      $ 365,482      $ 1,087,221      $ 1,117,028   

Selling, General & Administrative

     124,664        129,775        375,135        395,482   

Depreciation and Amortization **

     14,751        14,025        44,596        43,857   

Stock-Based Compensation Expense

     3,306        2,266        9,650        6,702   

 

* Includes a charge of $7.25 million related to the settlement of a lawsuit.

 

** Amount included within cost of sales and selling, general & administrative costs.


 

CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     September 30,
2010
     December 31,
2009
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 315,564       $ 372,714   

Accounts Receivable, net

     330,681         282,463   

Current Insurance Receivable - Asbestos

     35,300         35,300   

Inventories, net

     315,291         284,552   

Other Current Assets

     74,076         71,317   
                 

Total Current Assets

     1,070,912         1,046,346   

Property, Plant and Equipment, net

     273,487         285,224   

Long-Term Insurance Receivable - Asbestos

     187,420         213,004   

Other Assets

     385,506         406,346   

Goodwill

     778,180         761,978   
                 

Total Assets

   $ 2,695,505       $ 2,712,898   
                 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 1,424       $ 1,078   

Accounts Payable

     155,286         142,390   

Current Asbestos Liability

     100,300         100,300   

Accrued Liabilities

     224,066         218,864   

Income Taxes

     4,365         4,150   
                 

Total Current Liabilities

     485,441         466,782   

Long-Term Debt

     398,691         398,557   

Long-Term Deferred Tax Liability

     38,521         29,578   

Long-Term Asbestos Liability

     651,476         720,713   

Other Liabilities

     162,240         203,566   

Total Equity

     959,136         893,702   
                 

Total Liabilities and Equity

   $ 2,695,505       $ 2,712,898   
                 


 

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
September 30
    Nine Months Ended
September 30
 
     2010     2009     2010     2009  

Operating Activities:

        

Net income attributable to common shareholders

   $ 41,507      $ 35,108      $ 114,782      $ 86,185   

Noncontrolling interest in subsidiaries’ earnings

     96        45        168        202   
                                

Net income before allocations to noncontrolling interests

     41,603        35,153        114,950        86,387   

Gain on divestiture

     (1,015     —          (1,015     —     

Depreciation and amortization

     14,751        14,025        44,596        43,857   

Stock-based compensation expense

     3,306        2,266        9,650        6,702   

Deferred income taxes

     17,693        12,107        30,913        14,891   

Cash (used for) provided by operating working capital

     (35,721     33,659        (56,367     13,037   

Other

     (29,051 )*      5,029        (39,772 )*      (4,361
                                

Subtotal

     11,566        102,239        102,955        160,513   

Asbestos related payments, net of insurance recoveries

     (16,167     (22,253     (43,652     (34,788 )** 
                                

Total (used for) provided by operating activities

     (4,601     79,986        59,303        125,725   
                                

Investing Activities:

        

Capital expenditures

     (5,199     (3,827     (13,589     (21,259

Proceeds from disposition of capital assets

     143        1,001        185        3,326   

Proceeds from divestitures

     4,615        —          4,615        —     

Payment for acquisition - net of cash acquired

     —          —          (51,167     —     
                                

Total used for investing activities

     (441     (2,826     (59,956     (17,933
                                

Financing Activities:

        

Dividends paid

     (13,453     (11,695     (37,011     (35,079

Reacquisition of shares on open market

     (19,999     —          (29,989     —     

Stock options exercised - net of shares reacquired

     3,962        (546     16,351        (299

Excess tax benefit from stock-based compensation

     851        131        1,820        131   

Change in short-term debt

     834        (960     (2,299     (16,365
                                

Total used for financing activities

     (27,805     (13,070     (51,128     (51,612
                                

Effect of exchange rate on cash and cash equivalents

     12,882        7,824        (5,369     16,868   
                                

Increase (decrease) in cash and cash equivalents

     (19,965     71,914        (57,150     73,048   

Cash and cash equivalents at beginning of period

     335,529        232,974        372,714        231,840   
                                

Cash and cash equivalents at end of period

   $ 315,564      $ 304,888      $ 315,564      $ 304,888   
                                

 

* Includes a $25 million discretionary pension contribution.

 

** Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.


 

CRANE CO.

Order Backlog

(in thousands)

 

     September 30,
2010
    June 30,
2010
    March 31,
2010
    December 31,
2009
     September 30,
2009
 

Aerospace & Electronics

   $ 401,585   $ 394,554   $ 388,169   $ 351,004       $ 369,898 ** 

Engineered Materials

     11,367        12,496        14,810        12,070         8,454   

Merchandising Systems

     18,044        20,346        21,947        23,522         23,574   

Fluid Handling

     266,578        257,840        253,946        249,901         252,333   

Controls

     27,575        28,711        26,910        27,958         27,292   
                                         

Total Backlog

   $ 725,149      $ 713,947      $ 705,782      $ 664,455       $ 681,551   
                                         

 

* Includes Order Backlog of $24.5 million in September 2010, $26.5 million in June 2010 and $22.4 million in March 2010 pertaining to the 2010 acquisition of Merrimac.

 

** Includes Order Backlog of $15.0 million in September 2009 pertaining to the General Technology Corporation which was divested in December 2009.


 

CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
    Percent Change
September 30, 2010
    Percent Change
September 30, 2010
 
    2010     2009     2010     2009     Three Months     Nine Months  

INCOME ITEMS

           

Net Sales

  $ 560,714      $ 550,710      $ 1,643,819      $ 1,651,339        1.8     -0.5

Operating Profit

    62,879        55,453        181,463        138,829        13.4     30.7

Percentage of Sales

    11.2     10.1     11.0     8.4    

Special Items impacting Operating Profit:

           

Lawsuit Settlement—Pre-Tax (a)

    —          —          —          7,250       

Restructuring Charges (Gains)- Pre-Tax (b)

    (415     513        (1,165     2,360       
                                   

Operating Profit before Special Items

  $ 62,464      $ 55,966      $ 180,298      $ 148,439        11.6     21.5
                                   

Percentage of Sales

    11.1     10.2     11.0     9.0    

Net Income Attributable to Common Shareholders

  $ 41,507      $ 35,108      $ 114,782      $ 86,185       

Per Share

  $ 0.70      $ 0.60      $ 1.92      $ 1.47        16.9     31.1

Special Items impacting Net Income Attributable to Common Shareholders:

           

Lawsuit Settlement—Net of Tax (a)

    —          —          —          4,713       

Per Share

        $ 0.08       

Restructuring Charges (Gains)—Net of Tax (b)

    (348     345        (823     1,787       

Per Share

  $ (0.01   $ 0.01      $ (0.01   $ 0.03       
                                   

Net Income Attributable To Common Shareholders Before Special Items

  $ 41,159      $ 35,453      $ 113,959      $ 92,685        16.1     23.0
                                   

Per Share

  $ 0.69      $ 0.60      $ 1.91      $ 1.58        14.8     21.0

(a)     During the nine months ended September 30, 2009, the Company recorded a charge for the settlement of a lawsuit brought against the Company by a customer alleging failure of our fiberglass-reinforced plastic material.

    

(b)     Amounts represent restructuring charges (gains) in connection with the Restructuring Program.

   

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
             
    2010     2009     2010     2009              

CASH FLOW ITEMS

           

Cash Provided from Operating Activities before Asbestos—Related Payments

  $ 11,566      $ 102,239      $ 102,955      $ 160,513       

Asbestos Related Payments, Net of Insurance Recoveries

    (16,167     (22,253     (43,652     (34,788 )*     
                                   

Cash Provided from Operating Activities

    (4,601     79,986        59,303        125,725       

Less: Capital Expenditures

    (5,199     (3,827     (13,589     (21,259    
                                   

Free Cash Flow

  $ (9,800   $ 76,159      $ 45,714      $ 104,466       
                                   

 

* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance. In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.